UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2026
Commission File Number: 001-42452
WF
International Limited
(Exact name of registrant as specified in its charter)
No. 1110, 11th Floor, Unit 1, Building 7, No. 477,
Wanxing Road
Chengdu, Sichuan, China 610041
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Unregistered Sales of Equity Securities
Share Purchase Agreement
On June 24, 2026, the Company entered into a share purchase agreement (the
“Share Purchase Agreement”) with several investors (each a “Purchaser” and collectively, the “Purchasers”),
in connection with the issuance and sale (the “Private Placement”) of an aggregate of 1,680,671 ordinary shares, par value
$0.00001 per share, of the Company at $1.19 per share for an aggregate purchase price of $2,000,000. The parties anticipated closing the
Private Placement on or about June 26, 2026. The sale of the ordinary shares is being made pursuant to the provisions of Regulation S
promulgated under the Securities Act of 1933, as amended.
The foregoing description of the
Share Purchase Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by
reference to the full text of the agreement, a form of which is filed as Exhibit 10.1 hereto and incorporated by reference.
Waiver Agreement
On June 23, 2026, the Company also
entered into a waiver agreement (the “Waiver Agreement”) with The Benchmark Company, LLC (“Benchmark”), and Axiom
Capital Management, Inc. (“Axiom” and, together with Benchmark, the “Placement Agents”). Pursuant to the Waiver
Agreement, the Placement Agents waived their right of first refusal (the “ROFR”) granted to them pursuant to that certain
placement agency agreement dated November 4, 2025 (the “Placement Agency Agreement”), by and among the Company and the Placement
Agents, to act as lead or joint investment bankers, lead or joint book runners, lead or joint placement agents, and/or investment banker/advisor
for each and every future public and private equity and debt offering, including all equity-linked financings, for a period of 12 months
after the closing date of the Company’s registered direct offering completed on November 6, 2025 (the “2025 Offering”).
In consideration of the waiver, the Company agreed to pay the Placement Agents
a cash fee in the aggregate amount of $80,000 (the “Waiver Fee”), and an aggregate of 20,000 unregistered ordinary shares
of the Company bearing customary restrictive legends upon execution of the Waiver Agreement.
In addition, the Company agreed to reduce the exercise price of the warrants
issued to the Placement Agents (the “Placement Agent Warrants”) and the warrants issued to the investors in the 2025 Offering
from $25.00 per share and $3.8671 per share, respectively, to $1.19 per share, at which the Company sold its ordinary shares to investors
in the Private Placement.
The foregoing description of the
Waiver Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by reference
to the full text of the agreement, a copy of which is filed as Exhibit 10.2 hereto and incorporated by reference.
INCORPORATION BY REFERENCE
This Form
6-K and the exhibits thereto, including any amendment and report filed for the purpose of updating such document, shall be deemed to be
incorporated by reference into (1) the registration statement on Form F-3, as amended (File No. 333-295778), and (2) the
post-effective amendment on Form F-3 to the registration statement on Form F-1 (File No. 333-290595) of the Company, to the extent not
superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
| Number |
|
Description of Exhibit |
| 10.1 |
|
Form of Share Purchase Agreement |
| 10.2 |
|
Waiver Agreement, dated June 23, 2026, by and among WF International Limited,
The Benchmark Company LLC, and Axiom Capital Management, Inc. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
| |
WF International Limited |
| |
|
| |
By: |
/s/ Ke Chen |
| |
|
Ke Chen
Chief Executive Officer |
Dated: June 26, 2026